Graph Attention Based Prioritization of Disease Responsible Genes from Multimodal Alzheimer's Network
This work addresses gene prioritization for Alzheimer's disease, offering a novel method that could be extended to other complex disorders, but it is incremental as it builds on existing graph and transformer techniques.
The paper tackled the problem of prioritizing disease-associated genes for Alzheimer's disease by proposing NETRA, a multimodal graph transformer framework, which achieved a normalized enrichment score of about 3.9 for the Alzheimer's disease pathway, outperforming classical methods.
Prioritizing disease-associated genes is central to understanding the molecular mechanisms of complex disorders such as Alzheimer's disease (AD). Traditional network-based approaches rely on static centrality measures and often fail to capture cross-modal biological heterogeneity. We propose NETRA (Node Evaluation through Transformer-based Representation and Attention), a multimodal graph transformer framework that replaces heuristic centrality metrics with attention-driven relevance scoring. Using AD as a case study, gene regulatory networks are independently constructed from microarray, single-cell RNA-seq, and single-nucleus RNA-seq data. Random-walk sequences derived from these networks are used to train a BERT-based model for learning global gene embeddings, while modality-specific gene expression profiles are compressed using variational autoencoders. These representations are integrated with auxiliary biological networks, including protein-protein interactions, Gene Ontology semantic similarity, and diffusion-based gene similarity, into a unified multimodal graph. A graph transformer assigns NETRA scores that quantify gene relevance in a disease-specific and context-aware manner. Gene set enrichment analysis shows that NETRA achieves a normalized enrichment score of about 3.9 for the Alzheimer's disease pathway, substantially outperforming classical centrality measures and diffusion models. Top-ranked genes enrich multiple neurodegenerative pathways, recover a known late-onset AD susceptibility locus at chr12q13, and reveal conserved cross-disease gene modules. The framework preserves biologically realistic heavy-tailed network topology and is readily extensible to other complex disorders.